Actually, systemic infusion of miR-34a inhibitor or genetic ablation of endothelial miR-34a prevented downregulation of endothelial sirtuin-1 caused by hyperglycemia (Li et al., 2016). The gene discussed is SIRT1; the disease is Hyperglycemia.